pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
the cabinet
Drugs
8,127
products tracked ·
590
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
IMNN-001
Epithelial Ovarian Cancer
$IMNN
Imunon, Inc.
0
catalysts
Phase 3
INM-004
Typical Hemolytic Uremic Syndrome (Shiga-Toxin Associated Hemolytic Uremic Sy…
Inmunova SA
0
catalysts
Phase 3
IkT-001
Pulmonary Arterial Hypertension
$IKT
Inhibikase Therapeutics, Inc.
0
catalysts
Phase 3
← prev
page 4 of 20
next →
131
Pain
89
Neurology
1
JNJ-1900
Head And Neck Squamous Cell Carcinoma (HNSC)
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 3
JNJ-69968054
Escherichia coli Infections
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 3
JointStem
Osteoarthritis
Biostar Stem Cell Research Institute
0
catalysts
Phase 3
Jynneos
Smallpox
Bavarian Nordic AS
0
catalysts
Phase 3
K-161
Keratoconjunctivitis Sicca (Dry Eye)
Kowa Co Ltd
0
catalysts
Phase 3
KETOROLAC TROMETHAMINE
KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
Post-Operative Pain
Cyclooxygenase
Neumentum Inc
0
catalysts
Phase 3
KPL-387
Pericarditis
$KNSA
Kiniksa Pharmaceuticals International, plc
0
catalysts
Phase 3
LB-102
Schizophrenia
$LBRX
LB PHARMACEUTICALS INC
0
catalysts
Phase 3
LMN-201
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Lumen Bioscience Inc
0
catalysts
Phase 3
LNS-8801
Metastatic Melanoma
Linnaeus Therapeutics Inc
0
catalysts
Phase 3
MC-1
heart failure
$MCUJF
MEDICURE INC
0
catalysts
Phase 3
MH-002
Ulcerative Colitis
MRM Health NV
0
catalysts
Phase 3
MK-1406
Pandemic Influenza
$MRK
Merck & Co., Inc.
0
catalysts
Phase 3
MPC-06ID
rexlemestrocel-L
Chronic Low Back Pain (CLBP)
$MESO
MESOBLAST LTD
0
catalysts
Phase 3
MR-142
phentolamine mesylate
Nyctalopia (Night Blindness)
Adrenergic receptor alpha
$VTRS
Viatris Inc
0
catalysts
Phase 3
Maci
Articular Cartilage Defect
$VCEL
Vericel Corp
0
catalysts
Phase 3
Melpida
Paraplegia
Elpida Therapeutics
0
catalysts
Phase 3
Multikine
Head And Neck Squamous Cell Carcinoma (HNSC)
CEL-SCI Corp
0
catalysts
Phase 3
NA-831
Traneurocin
Alzheimer's Disease
Biomed Industries Inc
0
catalysts
Phase 3
NA-921
Rett Syndrome
Biomed Industries Inc
0
catalysts
Phase 3
NA-941
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Biomed Industries Inc
0
catalysts
Phase 3
NGN-401
Rett Syndrome
$NGNE
Neurogene Inc.
0
catalysts
Phase 3
NP-028
Coronavirus Disease 2019 (COVID-19)
$EBS
Emergent BioSolutions Inc.
0
catalysts
Phase 3
NPG-2044
Ovarian Cancer
Novita Pharmaceuticals Inc
0
catalysts
Phase 3
NRTX-1001
Epilepsy
Neurona Therapeutics Inc
0
catalysts
Phase 3
NTO-1151
Triapine
Cervical Cancer
Ribonucleotide reductase
Resilience Government Services Inc
0
catalysts
Phase 3
NTX-001
Peripheral Nerve Injury
Neuraptive Therapeutics Inc
0
catalysts
